Urinary gonadotrophins but not recombinant gonadotrophins reduce expression of VEGF120 and its receptors flt-1 and flk-1 in the mouse uterus during the peri-implantation period.

BACKGROUND Ovarian stimulation in humans might affect the perinatal outcome and be considered as a stress factor in the implantation process. In this study we compared the effects of recombinant and urinary gonadotrophins during the mouse peri-implantation period. METHODS Adult female CD1 mice were treated as follows (a) urinary hFSH and urinary hCG, (b) recombinant hFSH and recombinant hLH and (c) saline. The effects of the gonadotrophins on the expression of vascular endothelial growth factor120 (VEG120) and its receptors and the corticotrophin releasing hormone (CRH) system during the peri-implantation period were studied. The specific effects of the different gonadotrophins on the onset of implantation were also studied. RESULTS Urinary gonadotrophin treatment caused lower levels of VEGF120, flt-1 and flk-1 mRNA levels, reduced the size of the embryo implantation site, delayed implantation and prolonged the gestational period. Both urinary hFSH and urinary hCG contributed to the adverse effects. Levels of CRH and CRHR1 expression were not influenced. Recombinant gonadotrophin treatment did not alter any of the parameters studied. CONCLUSIONS Our results show that the VEGF system of the mouse uterus during the peri-implantation period is adversely affected by urinary gonadotrophins but not by recombinant gonadotrophins. The CRH system was not affected by the two types of gonadotrophins.

[1]  E. Karteris,et al.  Expression and signalling characteristics of the corticotrophin-releasing hormone receptors during the implantation phase in the human endometrium. , 2004, Journal of molecular endocrinology.

[2]  M. Keirse,et al.  Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies , 2004 .

[3]  I. Cameron,et al.  Ovulation induction/intrauterine insemination in infertile couples is associated with low-birth-weight infants. , 2003, American Journal of Obstetrics and Gynecology.

[4]  M. Gassmann,et al.  Expression of Hypoxia-inducible Factors in the Peri-implantation Mouse Uterus Is Regulated in a Cell-specific and Ovarian Steroid Hormone-dependent Manner , 2003, The Journal of Biological Chemistry.

[5]  R. Koos,et al.  Inhibition of Vascular Endothelial Growth Factor/Vascular Permeability Factor Action Blocks Estrogen-Induced Uterine Edema and Implantation in Rodents1 , 2002, Biology of reproduction.

[6]  E. D. de Kloet,et al.  Gonadotrophin stimulation reduces VEGF(120) expression in the mouse uterus during the peri-implantation period. , 2002, Human reproduction.

[7]  S. Dey,et al.  Adult tissue angiogenesis: evidence for negative regulation by estrogen in the uterus. , 2001, Molecular endocrinology.

[8]  G. Coukos,et al.  Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance , 2001, Nature Immunology.

[9]  P. Rogers,et al.  Role of vascular endothelial growth factor in endometrial vascular events before implantation in rats. , 2001, Reproduction.

[10]  T. D’Hooghe,et al.  Superovulation of female mice delays embryonic and fetal development. , 2001, Human reproduction.

[11]  S. Soker,et al.  Differential expression of VEGF isoforms and VEGF164‐specific receptor neuropilin‐1 in the mouse uterus suggests a role for VEGF164 in vascular permeability and angiogenesis during implantation , 2000, Genesis.

[12]  D. Valbuena,et al.  Ovarian stimulation and endometrial receptivity. , 1999, Human reproduction.

[13]  I. Aifantis,et al.  Expression of corticotrophin-releasing hormone in the mouse uterus: participation in embryo implantation. , 1999, The Journal of endocrinology.

[14]  R. Pijnenborg,et al.  The influence of in-vitro culture versus stimulated and untreated oviductal environment on mouse embryo development and implantation. , 1999, Human reproduction.

[15]  S. Kaul,et al.  A Novel Alternatively Spliced Form of Murine Vascular Endothelial Growth Factor, VEGF 115* , 1998, The Journal of Biological Chemistry.

[16]  S. Dey,et al.  Differential expression of vascular endothelial growth factor and its receptor mRNAs in the mouse uterus around the time of implantation. , 1995, The Journal of endocrinology.

[17]  C. Stournaras,et al.  Corticotropin-releasing hormone (CRH) is expressed at the implantation sites of early pregnant rat uterus. , 1995, Life sciences.

[18]  A. Romeu,et al.  Effect of recombinant human luteinizing hormone versus human chorionic gonadotrophin: effects on ovulation, embryo quality and transport, steroid balance and implantation in rabbits. , 1995, Human reproduction.

[19]  A. Romeu,et al.  Recombinant hormones: Effect of recombinant human luteinizing hormone versus human chorionic gonadotrophin: effects on ovulation, embryo quality and transport, steroid balance and implantation in rabbits , 1995 .

[20]  F. Helmerhorst,et al.  Follow-up of 30 pregnancies after embryo cryopreservation. , 1995, European journal of obstetrics, gynecology, and reproductive biology.

[21]  H. Phillips,et al.  Developmental expression of binding sites and messenger ribonucleic acid for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis. , 1993, Endocrinology.

[22]  R. Frydman,et al.  Pregnancy: The increased risk of complication observed in singleton pregnancies resulting from in-vitro fertilization (IVF) does not seem to be related to the IVF method itself , 1993 .

[23]  R. de Leeuw,et al.  Human chorionic gonadotropin in commercial human menopausal gonadotropin preparations. , 1993, Fertility and sterility.

[24]  T. Lyberg,et al.  Treatment with gonadotropins impaired implantation and fetal development in mice , 1993, Journal of Assisted Reproduction and Genetics.

[25]  G. Ertzeid,et al.  Adverse effects of gonadotrophin treatment on pre- and postimplantation development in mice. , 1992, Journal of reproduction and fertility.

[26]  G. Breier,et al.  Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. , 1992, Development.

[27]  C. O'neill,et al.  Elevated luteal phase estradiol:progesterone ratio in mice causes implantation failure by creating a uterine environment that suppresses embryonic metabolism. , 1990, Fertility and sterility.

[28]  D. Connolly,et al.  Vascular permeability factor, an endothelial cell mitogen related to PDGF. , 1989, Science.

[29]  C. O'neill,et al.  Failure of implantation in human in vitro fertilization and embryo transfer patients: The effects of altered progesterone/ estrogen ratios in humans and mice , 1987, Fertility and sterility.

[30]  Y. Yun,et al.  Effects of superovulatory doses of pregnant mare serum gonadotropin on oocyte quality and ovulatory and steroid hormone responses in rats. , 1987, Gamete research.

[31]  D. Armstrong,et al.  Effects of a superovulatory dose of pregnant mare serum gonadotropin on ovarian function, serum estradiol, and progesterone levels and early embryo development in immature rats. , 1981, Biology of reproduction.

[32]  B. Nisula,et al.  Characterization of a discrete degradation product of the human chorionic gonadotropin beta-subunit in humans. , 1980, The Journal of clinical endocrinology and metabolism.

[33]  A. Enders,et al.  A morphological analysis of the early implantation stages in the rat , 1967 .

[34]  A. Romeu,et al.  Recombinant-human luteinizing hormone (r-hLH) as ovulatory stimulus in superovulated does , 2005, Journal of Assisted Reproduction and Genetics.

[35]  K. L. Moore,et al.  The developing human , 1988 .

[36]  W. J. Silvia,et al.  Differences in the lateral mobility of receptors for luteinizing hormone (LH) in the luteal cell plasma membrane when occupied by ovine LH versus human chorionic gonadotropin. , 1985, Endocrinology.

[37]  A. Psychoyos.  Hormonal control of ovoimplantation. , 1973, Vitamins and hormones.